- Home
- TRDA vs RMAX Comparison
TRDA vs RMAX Comparison
Compare TRDA & RMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- RMAX
- Stock Information
- Founded
- TRDA 2016
- RMAX 1973
- Country
- TRDA United States
- RMAX United States
- Employees
- TRDA N/A
- RMAX N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- RMAX Real Estate
- Sector
- TRDA Health Care
- RMAX Finance
- Exchange
- TRDA Nasdaq
- RMAX Nasdaq
- Market Cap
- TRDA 220.1M
- RMAX 178.3M
- IPO Year
- TRDA 2021
- RMAX 2013
- Fundamental
- Price
- TRDA $5.62
- RMAX $8.97
- Analyst Decision
- TRDA Strong Buy
- RMAX Hold
- Analyst Count
- TRDA 3
- RMAX 1
- Target Price
- TRDA $25.67
- RMAX $9.00
- AVG Volume (30 Days)
- TRDA 260.6K
- RMAX 278.2K
- Earning Date
- TRDA 08-06-2025
- RMAX 07-29-2025
- Dividend Yield
- TRDA N/A
- RMAX N/A
- EPS Growth
- TRDA N/A
- RMAX N/A
- EPS
- TRDA N/A
- RMAX 0.48
- Revenue
- TRDA $79,476,000.00
- RMAX $298,162,000.00
- Revenue This Year
- TRDA N/A
- RMAX N/A
- Revenue Next Year
- TRDA N/A
- RMAX $1.64
- P/E Ratio
- TRDA N/A
- RMAX $18.59
- Revenue Growth
- TRDA N/A
- RMAX N/A
- 52 Week Low
- TRDA $4.93
- RMAX $6.90
- 52 Week High
- TRDA $21.79
- RMAX $14.31
- Technical
- Relative Strength Index (RSI)
- TRDA 43.81
- RMAX 64.29
- Support Level
- TRDA $5.09
- RMAX $8.55
- Resistance Level
- TRDA $5.47
- RMAX $8.93
- Average True Range (ATR)
- TRDA 0.41
- RMAX 0.31
- MACD
- TRDA 0.04
- RMAX 0.11
- Stochastic Oscillator
- TRDA 41.82
- RMAX 88.86
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.